PMID: 9420292Jan 7, 1998Paper
Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1
Journal of Virology
V N KimA J Kingsman
Abstract
The use of human immunodeficiency virus vectors for gene therapy is hampered by concern over their safety. This concern might be ameliorated, in part, if the viral accessory genes and proteins could be eliminated from the vector genomes and particles. Here we describe a minimal vector system that is capable of transducing nondividing cells and which does not contain tat, vif, vpr, vpu, and nef.
References
Sep 1, 1992·Virology·L Fan, K Peden
May 11, 1992·Journal of Virology·G L Buchschacher, A T Panganiban
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M I BukrinskyM Stevenson
Sep 1, 1991·The Journal of Clinical Investigation·T ShimadaA W Nienhuis
Jan 1, 1991·Journal of Virology·M PoznanskyJ Sodroski
May 3, 1990·Nature·B EnsoliF Wong-Staal
Nov 1, 1990·Journal of Virology·K A PageD R Littman
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·E F TerwilligerW A Haseltine
Jun 30, 1989·Cell·M EmermanK Peden
Sep 1, 1989·Journal of Virology·S Y KimD Baltimore
Sep 1, 1989·Journal of Virology·A LeverJ Sodroski
Mar 16, 1989·Nature·M H MalimB R Cullen
Sep 1, 1989·Journal of Virology·K StrebelM A Martin
Nov 1, 1995·Journal of Virology·J GoncalvesD Gabuzda
Dec 1, 1995·Journal of Virology·U SchubertK Strebel
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·A AlbiniB Ensoli
Aug 1, 1995·Journal of Virology·C Aiken, D Trono
Jul 28, 1995·Cell·D Trono
Oct 1, 1995·Journal of Virology·J B JowettI S Chen
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·G BarillariB Ensoli
Feb 1, 1995·Journal of Virology·D N LevyD B Weiner
Mar 1, 1995·The Journal of General Virology·J H RichardsonA M Lever
Feb 25, 1995·Nucleic Acids Research·Y SoneokaA J Kingsman
Jan 1, 1994·The Journal of Experimental Medicine·C A SpinaD D Richman
Jun 1, 1994·Journal of Virology·C ParolinJ Sodroski
Nov 1, 1994·Journal of Virology·R A Subbramanian, E A Cohen
Dec 1, 1994·Journal of Virology·A S ZolotukhinB K Felber
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·U von SchwedlerD Trono
Jul 19, 1994·Proceedings of the National Academy of Sciences of the United States of America·N K HeinzingerM Emerman
Sep 1, 1994·Journal of Virology·R CarrollD C St Louis
Jul 1, 1993·Journal of Virology·G LiD J Volsky
Oct 14, 1993·Nature·M I BukrinskyM Stevenson
Mar 1, 1994·Journal of Virology·J GuliziaM Stevenson
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·M BrayM L Hammarskjöld
Jan 1, 1994·The Journal of Experimental Medicine·M D MillerM B Feinberg
Aug 1, 1993·Journal of Virology·U von SchwedlerD Trono
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J LisziewiczR C Gallo
Mar 1, 1993·Journal of Virology·H SakaiA Adachi
Feb 26, 1993·Cell·D N LevyD B Weiner
Feb 1, 1996·Journal of Virology·S BourK Strebel
Apr 12, 1996·Science·L NaldiniD Trono
Apr 1, 1996·Journal of Virology·R K AkkinaI S Chen
Apr 1, 1996·Journal of Virology·G D RitterM J Mulligan
Jul 1, 1996·Journal of Virology·H YuJ P Dougherty
Sep 1, 1996·Journal of Virology·C TaberneroB K Felber
Aug 15, 1996·Virology·T A RizviM E Keeling
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·L NaldiniI M Verma
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·E PoeschlaF Wong-Staal
Sep 10, 1996·Human Gene Therapy·G RossB R Smith
Nov 1, 1996·Journal of Virology·P M CannonA J Kingsman
❮ Previous
Next ❯
Citations
Dec 4, 1998·Springer Seminars in Immunopathology·P D RobbinsY Chernajovsky
Feb 12, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·I J KulloR S Schwartz
Dec 22, 1999·Gene Therapy·K MitrophanousN Mazarakis
Jan 26, 2000·Human Gene Therapy·N DéglonP Aebischer
May 3, 2000·British Journal of Haematology·K M ArdeshnaS Devereux
Oct 24, 2000·Journal of Virology·J ReiserR O Brady
Nov 18, 2000·Gene Therapy·D NègreF L Cosset
May 8, 2001·Human Gene Therapy·S PandyaV Planelles
Apr 20, 2001·Journal of Virology·C M KowolikJ K Yee
Feb 24, 2001·Stem Cells·Y HanazonoK Ozawa
Dec 19, 2001·Human Gene Therapy·M Fuller, D S Anson
Oct 25, 2002·AIDS Research and Human Retroviruses·Chen LiangMark A Wainberg
Aug 12, 2003·Human Gene Therapy·Samantha L GinnIan E Alexander
Jan 16, 2004·Gene Therapy·B L StrangY Takeuchi
Mar 18, 2005·Gene Therapy·A LamikanraM W Carroll
Apr 20, 2005·Birth Defects Research. Part C, Embryo Today : Reviews·Naoya KobayashiNoriaki Tanaka
Jun 16, 2007·Cancer Gene Therapy·G SaragaE Costello
Nov 17, 2007·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·H EliyahuA J Domb
Sep 18, 2007·Molecular Biotechnology·Adam S Cockrell, Tal Kafri
Aug 4, 2009·PloS One·Michelle MillingtonSylvie Shen
Apr 14, 2011·Human Gene Therapy·Boro Dropulić
Jan 25, 2020·Viruses·Maria C Virgilio, Kathleen L Collins
Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
Jan 29, 1999·Science·H MiyoshiB E Torbett
Jul 26, 2000·Human Gene Therapy·J H SlingsbyA Slade
Nov 25, 2000·Journal of Hematotherapy & Stem Cell Research·Y HanazonoC E Dunbar
Jan 11, 2000·Journal of Virology·D S AnR E Donahue
Sep 15, 2000·Human Gene Therapy·T NakajimaM Hasegawa
Feb 8, 2003·DNA and Cell Biology·Ricardo Quinonez, Richard E Sutton
Jan 3, 2001·Blood·J DyallM Sadelain
Feb 13, 2002·AIDS Patient Care and STDs·Mario R Mautino, Richard A Morgan
Jun 12, 2001·Human Gene Therapy·J GatlinJ V Garcia
May 12, 2005·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·S C BeutelspacherM O McClure
Feb 12, 2008·Current Protocols in Molecular Biology·Ali Ramezani, Robert G Hawley
Oct 16, 2009·Cell Biology and Toxicology·Joanna L HowarthJames B Uney
Dec 9, 2016·Journal of Occupational and Environmental Medicine·Ryan SchlimgenJatin M Vyas
Sep 13, 2000·Drugs·W Walther, U Stein
Mar 10, 2001·Human Gene Therapy·J L DouglasG Veres
Nov 23, 2000·Journal of Virology·M Butsch, K Boris-Lawrie
Jun 2, 2001·Human Gene Therapy·D FarsonL Naldini
Sep 12, 2000·Gene Therapy·M R MautinoR A Morgan
May 29, 2004·The Journal of General Virology·Kevin V MorrisNiels C Pedersen
Sep 6, 2007·Stem Cells and Development·Sinae KimHyung Min Chung
Dec 20, 2005·The Journal of Pathology·Lawrence S YoungVivien Mautner
Jan 18, 2006·Human Gene Therapy·Liang-Fong WongNicholas D Mazarakis
Apr 9, 2002·Gene Therapy·M R Mautino, R A Morgan
Aug 5, 2003·The Journal of Gene Medicine·Karine BreckpotKris Thielemans
May 29, 2004·Tissue Engineering·Ying LiRobert E Hawkins
May 18, 2007·Journal of Biomolecular Screening·Nicholas A GrahamAnand R Asthagiri
Mar 7, 2020·BioTechniques·Sunhye Lee, David Cobrinik
Mar 15, 2002·Gene Therapy·B ZhangM Q Wei
❮ Previous
Next ❯
Related Concepts
Related Feeds
CREs: Gene & Cell Therapy
Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.
Related Papers
Nature Biotechnology
R ZuffereyD Trono
International Journal of Molecular Medicine
T FukumoriA Adachi
Journal of Virology
M GasmiS T Chen
Archives of Virology
T Yamada, A Iwamoto